NASDAQ: ZVSA
Zyversa Therapeutics Inc Earnings Dates, Reports, Calls

Zyversa Therapeutics earnings were -$8.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ZVSA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$2.3M, up 58.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ZVSA reported annual earnings of -$9.4M, with -91.1% growth.

ZVSA earnings history

Current Revenue
$0.0
Current Earnings
-$8.8M
Current Profit Margin
0%

ZVSA Return on Equity

Current Company
-109.5%
Current Industry
-60.2%
Current Market
31.5%
ZVSA's Return on Equity (-109.5%)... subscribe to Premium to read more.
High Return on Equity Performance

ZVSA undefined

Current Company
-44%
Current Industry
-2.5%
ZVSA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ZVSA announces earnings.

ZVSA undefined

Current Company
-94.05%
Current Industry
5.8%

ZVSA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ZVSA-$8.44M-$8.84MN/A-$5.16
OGEN-$10.11M-$10.33MN/A-$33.60
PCSA-$11.87M-$11.96MN/A-$3.08
PALI-$13.01M-$13.14MN/A-$6.80
LIXT-$3.31M-$3.32MN/A-$1.45

Zyversa Therapeutics Earnings Reports & History FAQ

What were Zyversa Therapeutics's earnings last quarter?

Zyversa Therapeutics (NASDAQ: ZVSA) reported Q1 2025 earnings per share (EPS) of -$0.73, up 83.89% year over year. Total ZVSA earnings for the quarter were -$2.26 million. In the same quarter last year, Zyversa Therapeutics's earnings per share (EPS) was -$4.53.

If you're new to stock investing, here's how to buy Zyversa Therapeutics stock.

Is Zyversa Therapeutics profitable or losing money?

As of the last Zyversa Therapeutics earnings report, Zyversa Therapeutics is currently losing money. Zyversa Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$8.84 million, a 90.94% decrease year over year.

What was ZVSA's earnings growth in the past year?

As of Zyversa Therapeutics's earnings date in Q2 2025, Zyversa Therapeutics's earnings has grown year over year. ZVSA earnings in the past year totalled -$8.84 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.